Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-04-04

Clinical Trial Update: Aneurysmal Subarachnoid Hemorrhage: Red Blood Cell Transfusion and Outcome [Phase 2, Phase 3]

View source ↗

Summary

This is a Phase 2/3 trial update evaluating red blood cell transfusion and outcomes in aneurysmal subarachnoid hemorrhage.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Subarachnoid Hemorrhage | Phase 2, Phase 3 | Status: COMPLETED